Channon-Wells, S. Et Al. 2023. Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study. LANCET RHEUMATOLOGY , vol.5, no.4 .

Channon-Wells, S., Vito, O., Mcardle, A. J., Seaby, E. G., Patel, H., Shah, P., ... Pazukhina, E.(2023). Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study. LANCET RHEUMATOLOGY , vol.5, no.4.

Channon-Wells, Samuel Et Al. "Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study," LANCET RHEUMATOLOGY , vol.5, no.4, 2023

Channon-Wells, Samuel Et Al. "Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study." LANCET RHEUMATOLOGY , vol.5, no.4, 2023

Channon-Wells, S. Et Al. (2023) . "Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study." LANCET RHEUMATOLOGY , vol.5, no.4.

@article{article, author={Samuel Channon-Wells Et Al. }, title={Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study}, journal={LANCET RHEUMATOLOGY}, year=2023}